Companies: 10,795·Total market cap: $144.5T
bioAffinity Technologies, Inc.

bioAffinity Technologies, Inc.

BIAFNASDAQHealthcare● Active
$1.59
$-0.01(-0.59%)
Market Cap$7213221
P/E Ratio
52W High$13.8
52W Low$0.693

bioAffinity Technologies, Inc. (BIAF) Revenue

Annual & quarterly revenue history · segment & region breakdown

BIAF · revenue · updated Jun 9, 2026

Core revenue metrics

bioAffinity Technologies, Inc. trailing twelve-month (TTM) revenue is $0.01B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.01B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
1.29×
mktCap ÷ TTM rev
Revenue per day
$0M
Est. TTM ÷ 365
Revenue / employee
$99K
57 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · bioAffinity Technologies, Inc. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
BIAF revenue by year · BIAF revenue history · BIAF annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income bioAffinity Technologies, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

bioAffinity Technologies, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from bioAffinity Technologies, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

BIAF revenue · 4 questions

BIAF's trailing twelve-month (TTM) revenue is $0.01B. That is an increase of 0.00% year-over-year from — in FY.

BIAF revenueBIAF annual revenuewhat is BIAF revenueBIAF TTM revenue

Source: FMP · bioAffinity Technologies, Inc. SEC filings · GAAP · bioAffinity Technologies, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026